Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in venous thromboembolism
IRCT20210416050990N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of rosuvastatin in venous thromboembolism (VTE) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Inflammatory complications of thrombotic disease such as post-thrombotic syndrome. Started Apr 2021; status: completed.
02
Drugs
rosuvastatin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20210416050990N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210416050990N1.